article

  1. 1,203 Posts.
    lightbulb Created with Sketch. 66
    Article in the Australian discussing the futures of various biotech companies. Avexa described as a potential 20-bagger and woefully undervalued.... but also at risk of going out the back door.

    http://www.theaustralian.news.com.au/story/0,25197,24441506-5001942,00.html
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.